Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3773043015 | Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3773044014 | Vascular endothelial growth factor receptor antagonist | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4167520015 | VEGF antagonist | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) | est un(e) (attribut) | Substance with receptor antagonist mechanism of action (substance) | true | Inferred relationship | Some | ||
| Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) | Has disposition (attribute) | Vascular endothelial growth factor receptor antagonist (disposition) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Sunitinib (substance) | est un(e) (attribut) | True | Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) | Inferred relationship | Some | |
| Sunitinib malate (substance) | est un(e) (attribut) | True | Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) | Inferred relationship | Some | |
| Intravitreal injection of anti-vascular endothelial growth factor | substance utilisée (attribut) | True | Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) | Inferred relationship | Some | 1 |
| bevacizumab | est un(e) (attribut) | True | Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) | Inferred relationship | Some | |
| ranibizumab | est un(e) (attribut) | True | Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) | Inferred relationship | Some | |
| Pegaptanib sodium (substance) | est un(e) (attribut) | True | Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) | Inferred relationship | Some | |
| Sorafenib (substance) | est un(e) (attribut) | True | Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) | Inferred relationship | Some | |
| Pegaptanib (substance) | est un(e) (attribut) | True | Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) | Inferred relationship | Some | |
| Vandetanib (substance) | est un(e) (attribut) | True | Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) | Inferred relationship | Some | |
| Axitinib (substance) | est un(e) (attribut) | True | Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) | Inferred relationship | Some | |
| Sorafenib tosylate (substance) | est un(e) (attribut) | True | Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) | Inferred relationship | Some | |
| Cabozantinib (substance) | est un(e) (attribut) | True | Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) | Inferred relationship | Some | |
| lenvatinib mésylate | est un(e) (attribut) | True | Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) | Inferred relationship | Some | |
| Pazopanib hydrochloride (substance) | est un(e) (attribut) | True | Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) | Inferred relationship | Some | |
| Pazopanib (substance) | est un(e) (attribut) | True | Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) | Inferred relationship | Some | |
| Lenvatinib | est un(e) (attribut) | True | Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) | Inferred relationship | Some | |
| Ramucirumab | est un(e) (attribut) | True | Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) | Inferred relationship | Some | |
| Regorafenib | est un(e) (attribut) | True | Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) | Inferred relationship | Some | |
| Aflibercept | est un(e) (attribut) | True | Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) | Inferred relationship | Some | |
| Brolucizumab (substance) | est un(e) (attribut) | True | Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) | Inferred relationship | Some | |
| Cabozantinib s-malate | est un(e) (attribut) | True | Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR